The recent trials for aspirin in the prevention of cardiovascular mortality J. H. ChesebroL. H. OpieV. Fuster Editorial Comment Pages: 353 - 354
Calcium channel antagonism and beta blockade in combination—A therapeutic alternative in cardiovascular disorders. A review Jan N. LessemBramah N. Singh Reviews Pages: 355 - 373
Vasodilator therapy without converting-enzyme inhibition in congestive heart failure—Usefulness and limitations Willem J. Remme Reviews Pages: 375 - 396
The effect of isradipine, a new calcium-channel antagonist, in patients with primary Raynaud's phenomenon: A single-blind dose-response study J LeppertT JonassonI Ringqvist Calcium Antagonists Pages: 397 - 401
Prolonged protective effect of the calcium antagonist anipamil on the ischemic reperfused rabbit myocardium: Comparison with verapamil Roberto FerrariRiccardo RaddinoOdoardo Visioli Calcium Antagonists Pages: 403 - 412
Nifedipine-prazosin interaction in patients with essential hypertension István KissCsaba Farsang Calcium Antagonists Pages: 413 - 415
Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses L. CarosellaP. MenichelliP. U. Carbonin Calcium Antagonists Pages: 417 - 425
Double-blind comparison of tiapamil and atenolol in patients with mild to moderate hypertension: A multicenter trial Roman SykulskiNiels KellerKurt Quitzau Hypertension Pages: 427 - 431
Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass Takashi NatsumeMerrill B. KardonEdward D. Frohlich Hypertension Pages: 433 - 439
Double-blind study on the interaction of oxaprozin with metoprolol in hypertensives A. HalabiM. LindeW. Kirch Hypertension Pages: 441 - 443
Effects of SIN-1 on peripheral hemodynamics and viscoelastic properties of aorta in anesthetized rabbits Alain FriggiHeidi BodardPierre H. Rolland Vasodilation Pages: 445 - 458
Study of ridazolol on isolated canine and human coronary arteries Philippe UngerGuy BerkenboomJeanine Fontaine Vasodilation Pages: 459 - 464
